生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | Penfluridol has robust antipsychotic efficacy and is a first-generation diphenylbutylpiperidine. Its effects last for several days after a single oral dose and it can be administered once a week to provide better compliance and symptom control. In addition; the anti-cancer effects of penfluridol have been demonstrated in vivo: results showed slight changes in the volume and weight of organs at doses tested in animals[3]. Penfluridol concentration-dependently suppressed the cell viability of AML cells with FLT3-WT (Fms-like tyrosine kinase 3) (HL-60 and U937) and FLT3-ITD (MV4-11); penfluridol's augmentation of intracellular ROS levels was critical for the penfluridol-induced autophagic response. The combination of penfluridol with an autophagy inhibitor may be a novel strategy for AML (acute myeloid leukemia) harboring FLT3-WT and FLT3-ITD[4]. Penfluridol treatment suppressed the growth of BxPC-3 tumor xenografts by 48% as compared to 17% when treated in combination with chloroquine. Similarly, penfluridol suppressed the growth of AsPC-1 tumors by 40% versus 16% when given in combination with chloroquine[5]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.91mL 0.38mL 0.19mL |
9.54mL 1.91mL 0.95mL |
19.09mL 3.82mL 1.91mL |
参考文献 |
---|